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The objectives of this study were to inves tigate the ab-
sorp tion of diazepam applied topically to the hairless mouse 
in vivo and to determine the diffusion of diazepam across 
isolated hairless mouse skin and human skin. [1 4CJDiazepam 
was readily absorbed after topical administration to the 
intact hairless mouse, a total of 75.8% of the 14C-label 
applied being recovered in urine and feces . 
Diazepam was found to diffuse across human and hairless 
mouse skin unchanged in experiments with twin-cham-
bered diffusion cells. The variation in diffusion rate or the 
flu x for both human and mouse tissues was grea ter among 
specimens than between duplicate or triplicate trials for a 
single specimen. Fluxes for mouse skin (stratum corneum, 
epidermis, and dermis) were greater than for human skin 
(s tratum corneum and epidermis): 0.35-0.61 p.g/cm2/h for 
mouse skin vs 0.24-0.42 p.g/cm2/h for human skin. The 
permeability coeffi cients for mouse skin ranged from 1.4-
2.4 x 1O - 2cm/h compared with 0.8-].4 x 1O - 2cm/h for 
human skin. Although human stra tum corneum is almost 
twice the thickness of that of the hairless mouse, the dif-
D iazepam (Valium, 7-chloro-l,3-dihydro-1-methyl-5-phenyl-2H-l,4-benzod iazepin-2-one) is a benzo-diazepine used as an anxiolytic, sedative, hypnotic, and anticonvulsant agen t as well as a skeletal muscle relaxant [1 ,2). Like many benzodi azepines , the bi-
ologic half-life of diazepam is long (20-50 h) , it is lipid soluble, 
and several metabolites possess pharmacologic ac tivity (3). Anx-
iolytic effects can be anticipated at blood concentrations of300-400 
ng/ml diazepam (3) . T hese characteristi cs compli cate the use of 
this type of drug topically. For example, the long biologic half-
life does no t assis t in effi cient delivery (4). However, diazepa m 
can be considered to be a good prototype for preliminary studies 
on the transdermal permea bility of benzodiazepine dru gs in gen-
eral. 
O bjectives of this study were to determine: (1) whether ra-
dio labeled diazepam is absorbed in vivo folJowing topica l admin-
istration to the hairless mouse, (2) the in vitro diffusion rates of 
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Abbreviations: 
D: dermis 
I-IPLC: high-performance liquid chro matography 
LSC: liqu id scintillation counting 
SCE: stratum co rneum and ep idermis 
fusion coefficients for human skin were 3-12 times grea ter 
(0.76- 3.31 X 10- 6 cm2/ h for human skin vs 0.12-0.27 X 
10 - 6 cm 2/h for hairless mouse) because of a shorter lag 
time for diffusion across human skin . These differences 
between the diffusion coeffi cients and diffusion rates (or 
permeability coefficients) sugges t that the presence of the 
dermis may present some barrier properties. [n vitro the 
dermis may require complete sa turation before the diaze-
pam can be detected in the receiving chamber. 
[14C ]Diazepam was not detected in the receiving cham-
ber of the Franz cell apparatus in experiments with human 
skin . This indicated that the rate of diffusion was less than 
0.09 p.g/ cm2 /h. Since this diffusion technique more closely 
resembles topical administration to humans , these results 
appear to indica te that achieving therapeutic concentrations 
in humans may be difficult. In addition, the hairless mouse 
may not be a suitable model for predicting percutaneous 
absorption of diazepam in humans : J 1m/est D errnalo / 88: 
582-585, 1987 
diazepam across hairl ess mouse skin and human skin , and (3) 
whether di azepam was meta bolized durin g diffusion. 
MATERIALS AND METHODS 
Diazepam was a gift of Hoffmann-La Roche Inc. (Nutley, N ew 
Jersey). [2-1 4C]Diazepam, sp act 54 m C i/ mmol (99% purity), was 
purchased fro m the Amersham Corp. (Arlington Heights, Illi-
nois). M ethanol for use in high-performan ce liquid chromatog-
raphy (HPLC) was purchased fro m Fisher Scientific (Itasca, 1.1-
Iinois). Water for HPLC was filtered throu gh a Milli Q System 
(Waters Associates , Milford , Massachusetts). Female hairless mice, 
6-9 weeks old , weighing 24-30 g, were purchased from Temple 
University (Philadelphia, Pennsylva nia). Twin-chambered dif-
fusion ceUs [5), designed with a magnetic stirring well in each 
chamber (2 ml per chamber) and a surface for diffusion of 0.79 
cm2, were made at the Research Resources Labora tory of the 
University of Illinois (Chicago, Illinois). An 8-cell Franz diffusion 
apparatus (5) with a 2.01-cm2 surface for diffusion was purchased 
from the C rown Glass Compan y (Somerv ille, New Jersey). 
In Vivo Mouse Experiments Diazepam. w as ad ministered top-
ically (1.0 /-Lg/ kg dose, 1 /-LC i in 0.05 ml 95% ethanol) over a 2-
cm2 area on the back of the neck with a H amilton microsy ringe 
(Reno, N evada). The solvent was allowed to evapo rate and the 
area was left un covered for 24 h. Animals were housed in N alge 
free-standing meta bolism cages (Fisher Scientific) to aid in the 
collection of urine and feces. 
The urine and feces were collected dail y for 3 days [6J and the 
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radiolabd ass:lyed by li q ui d scintill atio n co untin g (LSC, sec be-
low). For co mp:lrison , mi ce we n: also given thc sa me dose of 
diazcpa m i. p. (in 0.05 ml propy lcne g lyco l) :lnd their urin cs and 
feccs we re :l lso co llected and assayed for th e '~ C-labcl. 
Hairless Mouse Skin After all owing 2 weeks fo r "'C-labeled 
metabo li tes w ith a long biolog ic half- life to be excreted, th e mi ce 
used fo r the in vivo expe rim ents were sacrifi ced by cervica l dis-
locatio n . T he skin fro m the back was removed and tril11m ed o f 
fat a nd o ther cxtraneo us tiss ues . The who le skin , co mprising 
stratum co rn eum and epidermis (SCE) ;lIld dermis (D), was used 
fo r t h e diffu sion experim ents. 
HUITlan Skin Sa lll p ics o f w ho le human cadaver sk in werc re-
moved from the midl ine rcgion of the chest less tlun 48 h after 
deat h . T he subcuta neo us fat was trimmed and the tiss uc trea ted 
according to th e methods ofSwa rbrick et al1 71 bcfo re th e remova l 
o f thc SCE from the dermis. T he SCE ~/as then d ricd in a des-
iccato r ll1 ain ta ined at approxim ately 25% rcbtivc humidity for 
2-3 days. T he dried S:l lll pleS we re wrapped in aluminum fo il and 
sto red in the refri ge rato r at 5°C and rehyd rated by imillersing the 
tiss u e in water at roo m temperature for i h befo re usc 171. 
Diffusion Experiments Using Twin-Chambered Diffusion 
Cells Whole mouse skin (SCE and D) or hUl11 an skin (SCE) 
was placed between the two chambers of the twin-cham bercd 
cell s . Approx imately 50 J.L g of diazepam (- 0.23 J.LC i), disso lved 
in ethano l (0.05 1111), was added to the dono r (stratu m corncum) 
side o f thc ce ll conta inin g 2 ml of sa line. Sa line 2 ml was added 
to t h e rcceiving chamber and th e cells we re in cubated in a 35°C 
water bath. Two 0.05-1111 sa mples we rc takcn fro m the rcceivi ng 
cham.be r throug h the sa mplin g port at 0, 0.5, I, 2, 3, 4, 5, and 
6 h. Each sa mple was rcplaced with an equa l vo lumc of sa line. 
Samplcs werc assaycd for the "'C_labcl by a liquid scin till ation 
co unte r (sce LS C below). The scnsiti vity of this method wi ll 
detcct a diffu sion rate o f 0.1 a J.L g/cm 2/ h. 
Diffusion Experiments Using the Franz Cell Apparatus 
App roxim ately 50 J.L g of diazepam (0. 1 J.LC i) , dissolved in 0.05 
ml eth ano l, was placed o n the st ratum co rn eum sur face (- 2 C1112) 
and t h c ethan o l allowcd to eva po rate. T he receivin g chal11ber was 
kept a t 35°C by a circulatin g watcr bath. Two O.05-1ll1 sa l11ples 
of the sa line so lu tion in the rcce iving chambcr werc ta kcn at 0, 
0. 5, 1 , 2, 3, 4, 5, and 6 h through the sa mplin g side arm. Each 
sample was rcplaced by an eq ual vo lulTl c of sa l inc. Sa mpl cs we re 
assa ycd for thc "'C_label by LSC. T hc sensiti vity of thi s l11 ethod 
will detect :l diffusio n ratc o f 0.09 J.L g/cm 2 /h. 
Analysis of Samples by HPLC Samples fro m the dono r and 
recciv ing sidcs of th e twin-chambercd diffu sion cclls were storcd 
at - 20°C until analyzcd. Freshl y thawed sa mplcs (1-ml ali-
quot s) were cx tracted usin g a C- 18 Bond E lu t column (A na-
Iyt ic h cm In tern ati onal, Harbor C it y, C alifo rnia). The "'C_label 
was e luted fro m the Bond E lu t column with threc I-m l aliquo ts 
of methano l and analyzed by HPLC. A O. I-m l aliquot was ana-
lyzed w ith a Waters Associates liqu id chro matograph , m odel 50 1 
pl1 mp , U 6K inj ector, with :I J.LBondapak C I ~ radial compression 
colum n . T hc mobile phase was 65% mcthan o l/35% water (Milli 
Q fi l tcred) at a flow rate o f 2 ml / min [81. T hc HPLC eluate was 
monito red by a UV abso rbance detector, 1l1 odel 440, o perated at 
254 nm. T he eluate was collected in 20-m lliquid scintill at io n vials 
at 30- 5 intervals in preparation fo r LS C anal ysis. 
Liquid Scintillation Counting T he sa l11ples fro m diffusion 
ceUs a nd the eluate fra ctio ns from the HPLC we re phced in 20-
ml liqu id scintill ati on vials and 10 1111 of Budget- olvescintillation 
cockta il (Resea rch Prod ucts In te rnat io nal o rp ., Mount Pros pect, 
Illinois) added. Fo r urine sa mples, a 0. 1- to 0.2-1111 ali quot was 
pl aced in simil ar vials and 0.3 ml o f g lacial acetic acid was added 
before the additio n of lO ml o f cocktaiL 
Feca l sa mples were co ll ccted and weighed dai ly fo r each animal. 
A 24-h sa mple was placed in a 20-ml vial to w hich 10 ml of 
deio n ized disti lled water and 2-3 glass beads were addcd. T he 
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vials we re mi xed using a Vortex Gen ie mixer (Fisher Scientific), 
for 5-10 min o r until a homogeneous suspension was prepared . 
Two 0.2-g sa mples were weighed in to clean 20-ml scintillation 
vials and 0.3 ml of glacial acetic acid was added followed by 10 
ml of scin ti ll ation cocktail. All sa m ples we re measured for the 
1·1 -l abel with a Tri-Ca rb 4000 series liquid scintillation counter 
(85-95'Yo cfficicncy) fro m Packard Instrument Company, In c. 
(Dow ners G rove, Illino is). 
Calculation of Diffusion Rates or Flux 0) Diffusion ra tes 
o r flu x 0) were determined from the slo pe of the diffusion curves 
171 and cx pressed as the amount o f drug passi ng across a squ are 
centim cter of skin surface over tim e (J.Lg/cm 2/h). T he pamea bility 
coeffi cicnts (P) were determined by dividing the observed va lue 
fo r flu x by the initi al drug concentration in the dono r cell (25 
J.Lg/c I11 3). T his va lue cannot be deri ved for ex periments with the 
Fran z cell beca use the dono r so lvents are allowed to evaporate. 
A linea r regression program was used to determin e the eq uation 
o f the line for thc linear po rtion of the diffusion curve [9]. Fo l-
lowin g the determin ation of the lag time (tau, t) and skin thick-
ness (h) the diffusion coeffi cients (D) were calculated using D 
h2/6t [1 0 1· 
RES ULTS 
Absorption Across Hairless Mouse Skin In Vivo Follow ing 
topical admini stration of [2-' ~C]diazepam , recovery of the I~C­
label in urine and feces after 3 days was 54.8 ± 1.5% and 
21.0 ± 2.3% , res pectively. Total recovery of the label in urine 
and feces after 3 da ys was 75.8 ± 2.3% (Table I). After i.p. 
adm inistratio n, the recovery of the '4C_Iabel in urine and feces 
was 40.3 ± 6.4% and 47.2 ± 3.6%, res pectively. T he relat ive 
bioava ilabili ty of the '4C_Iabel applied topicall y co mpared w ith 
i. p . administration was g reater than 86%. T his indica tes that 
['4C ldiazepam was readily absorbed throu gh the hai rless mouse 
skin . 
Diffusion Across Hairless Mouse Skin in Vitro Thc diffu-
sion rates of [2- '4C 1diazepam using twin-chambered diffus ion 
cells and Franz diffusion cells were fo und to be similar to o ne 
ano th er fo r each mo use tiss ue. T he values ranged from 0.35-0.61 
J.Lg/crn 2/h (n = 3) (Table II ). Permeability coeffi cients were fo un d 
to ran ge from 1.4-2.4 X 10- 2 cm / h. The lag times ranged from 
0.50-1 .1 4 h determined from thc x-intercept va lues of regresssion 
lines that bes t fitted the diffusion curves (Fig 1). The diffusion 
coefficients ran gcd from 0. 12-0.27 X 10- 6 cm2/h and were found 
no t to be signifi cantly different for twin-chambered cells co m-
pared to Franz diffu sion cells. 
Hi gh- perfo rm ance liquid chromatog raph y analysis of the I.IC_ 
hble in the donor and receiving chambers of the twin-chambered 
diffusion ccll yiclded a single radioactivc peak with a retention 
time of 6.0 min , identica l to di azepa m. A typi ca l HPLC chro-
1l1 atog ram of l" 'Cldiazepam together with the radioactive data 
fro m eluate sa1l1ples analyzed by LSC is presented in Fig 2. 
Diffusion Across Human Skin In Vitro T he diffu sion rate 
of 1 2-'~C]diazepam usin g human skin and twin-chambered dif-
fusion cells ranged from 0.24-0.42 J.Lg/cm 2/ h (n = 3) (Ta ble Ill ). 
The permeability coeffi cients ranged from 0.8-1. 4 X 10- 2 cm /h. 
Table I. Rccovery of '4C-Label Fo.llowing Topica l and 
Intraperi toneal Administration of 12- '4C ]Diazepa m to 
Hai rless Mi ce 
ROllte of 
Recovery of 14e_Label (%) 
Administration Urine Feces Washes" Total 
In traperitonea l 40.3 ± 6.4 47.2 ± 3.6 N A 87 .9 ± 2.8 
(11 = 4) 
Topical (11 = 4) 54.8 ± 1.5 2 1. 0 ± 2.3 3.3 ± 1. 9 79.2 ± 2.3 
"The applicatioll site of topi cal administration was washed 3 times wi th I % Tween 
80 using cotto n swabs . T he swabs were placed in liquid scintilbtion vials. cocktai l 
was "dded, and the via ls counted . NA = nor applicable. 
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Table II. Diffusion Rates , Permeability Coefficients, and Diffusion Coefficients for Whole M o use Skin With Twin-Chambered 
and Franz Diffusion Cells 
Permeability 
Anirnal Diffusion Flux Coeffi cient La g Time Diffusion Coefficient 
No. Cell" (,Lg/cm2/h) (10 - 2 cm/h) (hours) (10 - 6 cm2/h" ) 
I-Tria l I TC 0.35 1.4 0.50 0.27 
Tria l 2 TC 0.39 1. 6 0.77 0.1 8 
2-Trial 1 TC 0.46 1. S O.S l 0. 17 
Trial 2 TC 0.44 1. 8 0.83 0.16 
3-Trial I TC 0.53 2. 1 0.62 0.22 
Trial 2 TC 0.61 2.4 0.90 0.15 
F 0.41 NA" 1.14 0.12 
2' F 0.48 NA 1.1 2 0. 12 
3 F 0.53 NA O.Yl 0. 15 
''Twin-chambered (T C) ce lls have 3 O.79-cm' surface area for diffu sion. Fran;; (f'j cells ha ve a 2.05-cm' surface arca for diffu sion. 
'Sec 11 31 for the thi ckness ofst"tul1l corn eum (0.<) X 10- ) CI1l) . 
cSkill tissue was no t the S;lII1C as # 2 lIsed for twin-chal1lbered cdls due to in~lIffi ci cnt amollnt o f skin . 
JNA = N ot appli ca ble with Franz diffusion cells. 
The la g times ranged from 0.13-0.64 h . and the diffusion coef-
fi cient ranged from 0.76-3.31 X 10 - 6 cm 2/h (Fig 3). Only di-
azepa m was found following HPLC and LSC analysis of th e 
contents of the receiving chamber. The diffusion rates in exper-
iments with the Franz cell could not be determined for the amounts 
of 14C-label detected were below the sensitivity of our assay (0.09 
J-Lgi cm 2 I h). 
DISCUSS IO N 
[2- 14C 1Diazepam was read ily absorbed through the intact sk in of 
the hairl ess mouse. The relative bioavailability of topi cally applied 
[14C ldiazepam compared with i. p. administration was greater than 
86%. These results suggest that most of the drug applied to the 
skin was absorbed over the 24-h treatment period . However, we 
w ere un able to determin e from these ex periments whether the 
absorbed materia l was diazepam o r its metabolites. 
Diazepam was found to diffuse un chan ged across both human 
SCE and whole mouse sk in. The diffusion rate of diazepam across 
hairless mouse skin in vitro was found to be simi lar for the twin-
chambered and Franz diffusion cells (range 0.35-0 .61 J-Lg/cm 2/h). 
The calcu lated perm eability coefficients for diazepam were greater 
than reported for proges terone and other compounds [11 , 121. In 
4.0 
) .2 
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0.0 ~ 
TlIne (Hours) 
Figure 1. Diffusion of diazepam across isolated hai rl ess mouse skin. 
Twin-chambered diffusion cells (ope" circles) and Franz ce lls (closed circles) 
(range as bars). 
general, the diffusion rates across mouse skin for both diffusion 
systems were g reater than across human skin (range 0.24-0.42 
J-Lg/cm 2/h) usi ng twin-cham bered cells. The whole mouse skin 
(- 0.44mm) used in these experiments was approximately 7 times 
thicker than human sk in (SCE - 0.06 mm , [13]). 
Since the stratum corneum is considered the m ajor barrier to 
diffusion, on ly the thickness of this layer was used in calculating 
the diffusion coefficients [14] . However, the calculated diffu sion 
coefficients for human skin were 3-12 times greater than for 
mouse skin (0.76-3.31 X 10 - 6 cm 2/h for hum an vs 0.12-0.27 X 
10 - 6 cm 2/ h for hairless m ouse). The thickness of human stra tum 
corneum (- 17 J-Lm) is approximately twice that of the hairless 
17 
11 
C> 
:E 
a. 
'" 
II 
:1 
f} L,j\ .... ~ .... _,J 
Tl ME (,.,INUTES) 
Figure 2. High-performance liquid chromatography and LSC data. A 
HPLC record showing the UV-absorbance of diazepam (dotted /itt e). The 
cluate was collected in liquid scintillation via ls at 30-s intervals and the 
dpm per sa mple plotted on the sa me scale (solid linc). 
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Table III. Diffusion Rates, Permeabi lity Coefficients, and Diffusion Coeffi cients for Human Skin With Twin-C hambered" 
Diffusion Cells 
Tissue I.D . Flux Permeability Coefficient Lag T ime Diffusion Coefficient 
No. 
I- Trial 1 
T rial 2 
Trial 3 
2-Trial 1 
3-Trial 1 
Trial 2 
(J.Lg/cm2/h) 
0.29 
0.30 
0.24 
0.28 
0.42 
0.38 
"Twi n-chambered (TC) cells have a O.79-cm' surr:,ce area fo r di ffusion. 
bSec [1 3-1 for thi ckness of hum an stratum co rneulll . 
(1 0- 2 cm/h) 
1. 2 
1. 0 
0.8 
0.9 
1.4 
1. 2 
mo u se (-9 ,um) and the human skin appeared to have a shorter 
lag p e riod than whole mouse skin; both factors greatly influence 
this calculation [1 0, 13]. The longer lag time for whole mouse 
skin indicates that the presence of the dermis may present some 
barrie r pro perties. 
R e p ea ted trials of a specimen of both human and mouse tissues 
varie d less than the individual specimens (Ta bles II, Ill). Because 
of the individual differences, data wre not pooled but their range 
of values are reported. 
One unexpected findin g was the lack of di ffu sion or a diffusion 
ra te less than the sensitivity of our assay (0.09 ,ug/cm2/ h) across 
human skin using Franz diffusion cells. This is probably due to 
the thickness of the human stratum corn eum and poss ibly to the 
physical state of the applied diazepam. Exposure to the atmos-
phere in the Franz cell will have removed solvent and the drug 
is like ly to be precipitated on the surface. In the twin-chambered 
cells the drug remains in solsution . Since the Franz cell more 
closely resembles the topical application of drugs to humans [5,15], 
it w ould appear to indicate that topical application in humans may 
prove to be diffi cult . Accelerants or penetration enhancers may 
be required in order to keep diazepam in solution to increase 
abso rption and reach effi cacious plasma concentrations [3, 16]. In 
addition , the hairless mouse may not be a suitable model for 
predic ting the percutaneous absorption of diazepam in humans. 
Z.4 
""~ 1. 6 I I 1 i 1 g 0.8 I I ! 0.0 • 
Ti me (Ho urs) 
Figure 3. D iffu sion of diazepam ac ross human isolated stratum corneum 
and epidermis. T w in-chambered diffusion cells (range as bars). 
(hours) (1 0 - 6 cm2/hh) 
0.64 0.76 
0.24 2.01 
0.19 3.31 
0.1 3 1.73 
0.43 1.1 2 
0.35 1.37 
In future experiments we plan to study the effe cts of the dermis 
on the diffusion rates and coeffi cients of diazepam with hairless 
mouse skin. The effects of accelerants on diazepam diffusion will 
be investigated to improve the flu x so as to approach therapeutic 
plasma concentrations . 
We wish to tlJar,k Dr. Geoffrey W. ). Lee fo r vaillable disCllssiom in the prep-
aratioll of this IIIQ/IIlScript. 
1. Pignataro FP: Experience with chemotherapy in refractory psychi-
atric disorders. C urrent T herapeutic Research 4:389- 398, 1962 
2. Katz RA , Aides JH, Rector M: A new drug approach to muscle 
relaxa tion. J N europsychiat 3 (suppl 1):91-95, 1962 
3. Baldessarini RJ: Drugs and the trea tment of psychiatric disorders, 
in Goodman and Gilman's The Pharmacological Basis of Thera-
peutics, 7th ed. Edited by AG Gilman, LS Goodman, TW Rail , 
F Murad. N ew York, Macmillan, 1985, pp 436 
4. RobinsonJR: Sustained and Controlled Release D rug Delivery, N ew 
York, Marcel Dekker. 1978, p 656 
5. Franz TJ: The finite dose technique as a valid ill vitro model for the 
study of percutaneous absorption in man. C urr Probl Dermatol 
7:58-68, 1978 
6. Schwartz MA, Koechlin BA, Postma E. Palmer S, Krol G: Metab-
o lism of diazepam in rat, dog and man. J Pharmacol Exp Ther 
149:423-435. 1965 
7. Swarbrick J , Lee G, Brom J: Drug permeation through human skin 
I: Effect of storage conditions of sbn. J Invest Dermatol 78 :63-66, 
1982 
8. Brodie RR, C hasseaud LF, Tylor T: High performance liquid cln o-
matographic determination of benzoidazepines in human plasm a. 
J C hromatogr 150:361-366, 1978 
9. Freund JE: Regression and correlation, in Mathematical Statisti cs. 
2d cd .• Englewood C li ffs, NJ , Prentice-Hall , 1971, pp 358-372 
10. Swarbrick J, Lee G, Brom J , Gensmantel NP: Drug permeation 
through human skin II : Permeability of ionizable compounds. J 
Pharm Sci 73:1 352-1355, 1984. 
11. Scheu plein RJ, Blank IH, Brauner GJ. MacFarlane DJ: Percutaneous 
absorption of steroids. J Inves t Dermatol 52:63- 70, 1969 
12. Scheu plein Rj: The Physiology and Pathophysiology of the Skin, 
vol 5. Edited by A Jarrett. N ew York, Academic Press, 1978. pp 
1669- 1752 
13. Bronaugh RL, Stewart RF, Congdon ER: Methods for in vitro per-
cutaneous absorption studies II : Animal models for human skin . 
Toxicol Appl Pharmacol 62:481-488, 1982 
14. Scheu plein RJ: Percutaneous absorption after twenty-five yea rs: or 
"old wine in new wineskins." J Inves t DermatoI 67:31-38, 1976 
15. Franz TJ: Percutaneous absorption. On the relevance of hI vitro data. 
J Inves t Dermatol 64:190- 195. 1975 
16. Guy RH, Hadgraft J: Transdermal drug delivery: the ground rules 
are emerging. Pharmacy lnt 6: 11 2-116, 1985 
